On July 14, 2025, Silexion Therapeutics Corp reconvened its annual meeting to elect new board members and approved a reverse share split of 1-for-15, with 59.6% in favor. They also ratified the appointment of auditors and increased shares for the 2024 Equity Incentive Plan, but some proposals saw lower support.